Our results from this study provide new insights into a molecular mechanism for the regulation of sE-cad levels in human lung cancer cell media by nicotine, BDNF, and/or β-AR ligands, which can likely offer novel therapeutic opportunities aimed at targeting this regulatory network. This evidence concerns the gene BDNF and lung carcinoma.